Literature DB >> 34916213

Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show.

Owen Dyer1.   

Abstract

Entities:  

Year:  2021        PMID： 34916213     DOI： 10.1136/bmj.n3104

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  23 in total

1.  Management experience of a designated hospital for children with coronavirus disease 2019.

Authors:  Jian-Guo Zhou; Qiao-Ling Fan; Chun-Mei Lu; Pu Xu; Gang-Feng Yan; Ling-Feng Chunyu; Ya-Zun Liu; Yi-Wei Chen; Yan-Ming Lu; Ting Zhang; Hui Yu; Li-Bo Wang; Jiang-Jiang Xu; Wen-Hao Zhou
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

2.  SARS-CoV-2: phenotype, genotype, and characterization of different variants.

Authors:  Mohammadreza Saberiyan; Elham Karimi; Zahra Khademi; Parvaneh Movahhed; Amir Safi; Ameneh Mehri-Ghahfarrokhi
Journal:  Cell Mol Biol Lett       Date:  2022-06-17       Impact factor: 8.702

3.  Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods.

Authors:  Le Duc Huy; Chung-Liang Shih; Yao-Mao Chang; Nhi Thi Hong Nguyen; Phan Thanh Phuc; Tsong-Yih Ou; Chung-Chien Huang
Journal:  Vaccines (Basel)       Date:  2022-06-13

4.  The feasibility, safety, and efficacy of Paxlovid treatment in SARS-CoV-2-infected children aged 6-14 years: a cohort study.

Authors:  Gangfeng Yan; Jianguo Zhou; Haitao Zhu; Yiwei Chen; Yanming Lu; Ting Zhang; Hui Yu; Libo Wang; Hong Xu; Zheng Wang; Wenhao Zhou
Journal:  Ann Transl Med       Date:  2022-06

Review 5.  Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant.

Authors:  Vineet Sharma; Himanshu Rai; Dev N S Gautam; Pradeep K Prajapati; Rohit Sharma
Journal:  J Med Virol       Date:  2022-02-03       Impact factor: 20.693

6.  The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Authors:  Jaffar A Al-Tawfiq; Van-Thuan Hoang; Nhat Le Bui; Dinh-Toi Chu; Ziad A Memish
Journal:  J Epidemiol Glob Health       Date:  2022-01-28

Review 7.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

Review 8.  SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants.

Authors:  Almu'atasim Khamees; Jamal Bani-Issa; Mazhar Salim Al Zoubi; Taqwa Qasem; Manal Issam AbuAlArjah; Sura Ahmad Alawadin; Khayry Al-Shami; Farah E Hussein; Emad Hussein; Ibrahim H Bashayreh; Murtaza M Tambuwala; Mohannad Al-Saghir; Christopher T Cornelison
Journal:  Pathogens       Date:  2022-02-20

Review 9.  SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.

Authors:  Evgenii Gusev; Alexey Sarapultsev; Liliya Solomatina; Valeriy Chereshnev
Journal:  Int J Mol Sci       Date:  2022-02-02       Impact factor: 5.923

10.  Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents.

Authors:  Chengbao Ma; Xianying Chen; Fanghua Mei; Qing Xiong; Qianyun Liu; Lianghui Dong; Chen Liu; Wenjing Zou; Faxian Zhan; Bing Hu; Yingle Liu; Fang Liu; Li Zhou; Junqiang Xu; Yongzhong Jiang; Ke Xu; Kun Cai; Yu Chen; Huan Yan; Ke Lan
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.